
UnitedHealth Group, Johnson & Johnson, and Medtronic are the three Healthcare stocks to watch today, according to MarketBeat’s stock screener tool. Healthcare stocks are shares of companies involved in medical goods and services, including pharmaceuticals, biotechnology, medical device makers, hospitals and clinics, insurers, and other healthcare service providers. Investors view them for potential growth driven by innovation and aging populations and as relatively defensive holdings, but they also face industry-specific risks like regulatory approvals, clinical trial outcomes, patent expirations, and reimbursement pressures. These companies had the highest dollar trading volume of any Healthcare stocks within the last several days.
UnitedHealth Group (UNH)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Johnson & Johnson (JNJ)
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.
Read Our Latest Research Report on JNJ
Medtronic (MDT)
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.
Read Our Latest Research Report on MDT
See Also
- MarketBeat’s Top Five Stocks to Own in April 2026
- WD-40 Company Justifies Sell-Side Support With Q2 Results
- Why PriceSmart’s Discount May Not Last Much Longer
- Levi Strauss Gains as DTC Continues to Fuel Revenue Growth
- Broadcom Locks in Multi-Year AI Wins With Google and Anthropic
- RPM International’s Blowout Quarter Sparks a 15% Rally
